Metronidazole Zentiva Pharma (Metronidazole)

Metronidazole penetrates susceptible microorganisms and is reduced by anaerobic cellular proteins to form nitro radical anions. These reactive species damage DNA and inhibit nucleic acid synthesis, leading to bacterial and protozoal cell death. The reduction process is selective for anaerobic organisms, providing targeted antimicrobial activity while sparing most aerobic cells.

The dosage of Metronidazole Zentiva Pharma is individualized by the prescribing clinician according to the infection type, severity, patient age, weight, renal and hepatic function, and local treatment guidelines. Patients should follow the exact regimen written on the prescription and consult their healthcare provider for any adjustments.

Metronidazole is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It may be used during pregnancy only when clearly needed. Small amounts are excreted in breast milk; breastfeeding mothers should discuss potential risks and benefits with their physician.

To request Metronidazole Zentiva Pharma, visit the product page on gnhindia.com, enter the desired quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and required import documentation.

Metronidazole offers a broad spectrum against anaerobic bacteria and certain protozoa, often preferred for its oral availability and cost‑effectiveness. Compared with clindamycin or beta‑lactam/beta‑lactamase inhibitor combinations, it has a lower risk of Clostridioides difficile overgrowth but may cause a disulfiram‑like reaction with alcohol. Choice depends on pathogen susceptibility, patient tolerance, and clinical guidelines.

Metronidazole Zentiva Pharma should be stored at ambient temperature, below 25 °C, in its original container to protect from moisture and light. Keep the product out of reach of children and do not use after the expiration date. No special refrigeration is required for this oral formulation.

The medication is taken orally, usually with food or a full glass of water to reduce gastrointestinal irritation. Tablets should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional. The exact schedule, including frequency and duration, is determined by the prescriber based on the infection being treated.

Serious adverse reactions, though uncommon, include seizures, peripheral neuropathy, severe allergic responses such as anaphylaxis, and hepatotoxicity. Patients should seek immediate medical attention if they experience neurological symptoms, rash with swelling, or signs of liver dysfunction. Monitoring is especially important in individuals with pre‑existing liver or kidney disease.

Metronidazole is contraindicated in individuals with a known hypersensitivity to the drug or other nitroimidazole compounds. It should also be avoided in patients with severe hepatic impairment unless benefits outweigh risks, and in those who cannot abstain from alcohol during therapy due to the risk of a disulfiram‑like reaction. Pregnant or breastfeeding women should only use it when clearly indicated by a physician.